Carlyle in talks to buy Baxter's kidney care unit, source says
WEBJul 5, 2024 · Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter...
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care …
WEBAug 13, 2024 · Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ:CG) today announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter's Kidney Care segment, to be named Vantive, for $3.8 billion.
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care …
WEBAug 13, 2024 · Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle For $3.8 Billion. Establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources. Sale follows robust process focused on maximizing stockholder value. Provides increased flexibility to …
Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion
WEBAug 13, 2024 · NEW YORK (Reuters) -Buyout firm Carlyle Group struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday. The proceeds from the deal, which...
Carlyle in Talks to Buy Baxter's Kidney Care Unit, Source Says
WEBJul 5, 2024 · (Reuters) -Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar...
Carlyle in Advanced Talks to Acquire Baxter’s Vantive
WEBJul 5, 2024 · Private-equity firm Carlyle Group CG 1.87% is in exclusive talks to acquire medical-device maker Baxter’s kidney-care spinoff Vantive for more $4 billion, including debt.
Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion
WEBAug 13, 2024 · NEW YORK (Reuters) -Buyout firm Carlyle Group struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday. The proceeds from the deal, which...
Baxter gains amid report in talks to sell kidney care spinoff to ...
WEBBaxter International (NYSE:BAX) rose 4% after a report that private equity firm Carlyle Group (CG) is in talks to acquire the kidney care spinoff for more than $4 billion, including debt.
Carlyle to Buy Baxter Kidney-Care Unit for $3.8 Billion
WEBAug 13, 2024 · Baxter International Inc. said it will sell its kidney-care unit to the Carlyle Group private equity firm for $3.8 billion, part of the health care company’s efforts to streamline and pay...
Carlyle in talks to buy Baxter's kidney care unit, source says
WEBJul 5, 2024 · (Reuters) -Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with...
- Some results have been removed